PubRank

Josep-Maria Ribera

Author PubWeight™ 51.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Statistical reviewers improve reporting in biomedical articles: a randomized trial. PLoS One 2007 1.49
2 Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group. Haematologica 2010 1.44
3 Frequency of ABL gene mutations in chronic myeloid leukemia patients resistant to imatinib and results of treatment switch to second-generation tyrosine kinase inhibitors. Med Clin (Barc) 2013 1.38
4 High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer 2008 1.30
5 Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood 2013 1.13
6 Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance. Blood 2011 1.03
7 The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy. Haematologica 2005 1.02
8 Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas. Histopathology 2011 1.01
9 Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine. Leuk Lymphoma 2003 0.97
10 Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study. Am J Hematol 2011 0.95
11 Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study. Haematologica 2005 0.94
12 Predictive factors for poor peripheral blood stem cell mobilization and peak CD34(+) cell count to guide pre-emptive or immediate rescue mobilization. Cytotherapy 2012 0.92
13 [Analysis of the implementation of a Joint Accreditation Committee of the International Society for Cellular Therapy and European Group for Blood and Marrow Transplantation acreditation in a clinical program of hematopoietic progenitor cell transplantation]. Med Clin (Barc) 2010 0.90
14 Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience. Int J Hematol 2007 0.89
15 Compassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 cases. Haematologica 2006 0.89
16 Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients. Leuk Lymphoma 2005 0.89
17 Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era. Eur J Haematol 2010 0.88
18 Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Eur J Haematol 2006 0.88
19 Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma. Cancer Genet Cytogenet 2010 0.88
20 Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome. Am J Hematol 2007 0.88
21 Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis. Cancer 2006 0.87
22 Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study. Haematologica 2003 0.87
23 Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how. Haematologica 2011 0.87
24 Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma. Eur J Haematol 2014 0.86
25 Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation. Br J Haematol 2014 0.86
26 Human immunodeficiency virus-related non-Hodgkin's lymphoma. Haematologica 2008 0.86
27 Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study. Cancer 2014 0.86
28 Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphoma. Hum Pathol 2004 0.85
29 Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis. Int J Hematol 2007 0.85
30 Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source. Biol Blood Marrow Transplant 2010 0.85
31 Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP. Br J Haematol 2012 0.85
32 Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART. Haematologica 2008 0.84
33 Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes. Leuk Lymphoma 2013 0.83
34 Improved outcome of AIDS-related lymphoma in patients with virologic response to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003 0.82
35 In vivo quantification of response to treatment in patients with multiple myeloma by 1H magnetic resonance spectroscopy of bone marrow. MAGMA 2007 0.81
36 Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients. Leuk Lymphoma 2014 0.81
37 Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study. Med Clin (Barc) 2008 0.80
38 Anorectal lymphoma without effusion associated with human herpesvirus-8 and type 1 Epstein-Barr virus in an HIV-infected patient. Hum Pathol 2003 0.79
39 Systemic lupus erythematosus in a patient with primary MALT lymphoma of the larynx. Ear Nose Throat J 2009 0.79
40 Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infection. Leuk Lymphoma 2010 0.79
41 Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol. Haematologica 2004 0.78
42 Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine. Haematologica 2013 0.78
43 Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis. Ann Hematol 2014 0.78
44 Oral induction and consolidation chemotherapy with idarubicin and etoposide in elderly patients with acute myeloid leukemia. Haematologica 2003 0.78
45 [Alveolar haemorrhage and HELLP syndrome]. Med Clin (Barc) 2007 0.78
46 [Sustained remission in an adult patient with Langerhans cell histiocytosis following T-cell depleted allogenic cell transplantation]. Med Clin (Barc) 2006 0.77
47 [Thrombotic thrombocytopenic purpura during treatment with interpheron]. Med Clin (Barc) 2007 0.77
48 Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients. Leuk Lymphoma 2014 0.76
49 Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients. Med Clin (Barc) 2010 0.76
50 Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain. Med Clin (Barc) 2008 0.76
51 [Similar prognosis for transplanted and non-transplanted patients with hematological malignancy admitted to the intensive care unit]. Med Clin (Barc) 2008 0.76
52 Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia. Br J Haematol 2002 0.76
53 [Osteoporosis as a first manifestation of systemic mastocytosis. Study of 6 cases]. Med Clin (Barc) 2007 0.76
54 Lack of impact of human immunodeficiency virus infection on the outcome of lymphoma patients transferred to the intensive care unit. Leuk Lymphoma 2012 0.76
55 Adverse prognosis of bulky disease in good-risk DLBCL. Lancet Oncol 2008 0.75
56 Leukaemic vasculitis from myelodysplastic syndrome in context. Lancet 2015 0.75
57 [Prognosis of the hematologic patients admitted to an Intensive Care Unit]. Med Clin (Barc) 2012 0.75
58 Progressive multifocal leukoencephalopathy shortly after the diagnosis of follicular lymphoma in a patient treated with fludarabine. Haematologica 2002 0.75
59 [Response to rituximab in two patients with plasma exchange-refractory thrombotic thrombocytopenic purpura]. Med Clin (Barc) 2010 0.75
60 Flow cytometry for detection of central nervous system disease in acute myeloid leukemia. Leuk Lymphoma 2015 0.75
61 [Improvements in the treatment of T-cell acute lymphoblastic leukemia in children]. Med Clin (Barc) 2012 0.75
62 Plerixafor plus G-CSF in combination with chemotherapy for stem cell mobilization in a pediatric patient with Ewing's sarcoma. J Clin Apher 2012 0.75
63 [Outbreak of blastoschysomics spp infection in a haematology unit: study of 6 cases and finding of the source of infection]. Med Clin (Barc) 2009 0.75
64 HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine. AIDS 2017 0.75
65 Translocation (18;22)(q21;q11.2) in B-cell lymphoproliferative disorders: a report of six cases. Leuk Lymphoma 2014 0.75
66 Chronic myelomonocytic leukemia diagnosed by means of mutational analysis in a patient with persistent monocytosis and tuberculosis. Leuk Lymphoma 2013 0.75
67 Advanced stage is the most important prognostic factor for survival in patients with systemic acquired immunodeficiency syndrome-related non-Hodgkin's Lymphoma treated with CHOP and highly active antiretroviral therapy. Int J Hematol 2007 0.75
68 [Association over time of Hodgkin lymphoma and non-Hodgkin lymphoma: study of 6 patients in one single center]. Med Clin (Barc) 2012 0.75
69 A case of non-lethal pulmonary air embolism after leukapheresis catheter removal. J Clin Apher 2005 0.75
70 Systemic thrombotic thrombocytopenic purpura (TTP) following unrelated cord blood transplantation. Leuk Lymphoma 2006 0.75
71 [High-dose ifosfamide and etoposide regimen as salvage and mobilization therapy for patients with lymphoma]. Med Clin (Barc) 2008 0.75
72 Neoplasms and infections as the main causes of death in patients in complete response to HIV-related non-Hodgkin lymphoma in the combination antiretroviral therapy era: a study out of a series of 146 patients. Br J Haematol 2013 0.75
73 [Massive skin infiltration followed by central nervous system infiltration in a patient with chronic myelomonocytic leukemia]. Med Clin (Barc) 2009 0.75
74 [Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases]. Med Clin (Barc) 2007 0.75
75 HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma. AIDS 2017 0.75
76 Metabolic fingerprinting of fresh lymphoma samples used to discriminate between follicular and diffuse large B-cell lymphomas. Exp Hematol 2009 0.75
77 [Diagnosis, prophylaxis and treatment of central nervous system involvement by non-Hodgkin lymphoma in HIV-infected patients]. Med Clin (Barc) 2009 0.75
78 [Sustained remission following autologous recovery after non-myeloablative stem cell transplantation in a patient with Hodgkin's lymphoma]. Med Clin (Barc) 2009 0.75
79 [Spontaneous complete remission in two patients with chronic lymphocytic leukemia]. Med Clin (Barc) 2010 0.75
80 [Therapy-related acute leukemia: study of 23 pacients]. Med Clin (Barc) 2011 0.75
81 [Acute myeloid leukemia with MOZ/CBP rearrangement]. Med Clin (Barc) 2004 0.75
82 HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era. AIDS 2015 0.75
83 [Neurologic complications following hematopoietic stem cell transplantation. Study of 14 patients]. Med Clin (Barc) 2005 0.75